Skip to main content

Table 4 Specificity and sensitivity to detect OC in pre-diagnostic UKCTOCS samples are shown for the complete sample set (A), as well as for samples split according to DNA concentration below (low DNA) (B) and above (high DNA) (C) the median and with a CA125 concentration < 35 IU/mL (CA125-negative samples) in the three groups. Definitions of DNA methylation positivity are provided in Table 1

From: The potential of circulating tumor DNA methylation analysis for the early detection and management of ovarian cancer

(A)

All samples

CA125-negative samples

0–2 years

0–1 years

1–2 years

0–2 years

0–1 years

1–2 years

Specificity (CI%)

96.9% (90.8–98.6)

96.9% (90.8–98.6)

96.9% (90.8–98.6)

96.8% (91.5–99)

96.8% (91.5–99)

96.8% (91.5–99)

Sensitivity (CI%)

23.3% (12.3–39)

31.6% (13.6–56.5)

16.7% (5.5–38.2)

15.4% (5–35.7)

22.2% (3.9–59.8)

11.8% (2.1–37.8)

(B)

Low DNA samples

CA125-negative samples

0–2 years

0–1 years

1–2 years

0–2 years

0–1 years

1–2 years

Specificity (CI%)

88.1% (77.3–94.3)

88.1% (77.3–94.3)

88.1% (77.3–94.3)

87.5% (76.3–94.1)

87.5% (76.3–94.1)

87.5% (76.3–94.1)

Sensitivity (CI%)

57.9% (34.0–78.9)

55.6% (22.7–84.7)

60.0% (27.4–86.3)

63.6% (31.6–87.6)

66.7% (24.1–94.0)

60% (17.0–92.7)

(C)

High DNA samples

CA125-negative samples

0–2 years

0–1 years

1–2 years

0–2 years

0–1 years

1–2 years

Specificity (CI%)

90.3% (79.5–96)

90.3% (79.5–96)

90.3% (79.5–96)

90.2% (79.2–95.9)

90.2% (79.2–95.9)

90.2% (79.2–95.9)

Sensitivity (CI%)

12.5% (3.3–33.5)

30% (8.1–64.6)

0% (0–26.8)

0% (0–25.3)

0% (0–69)

0% (0–30.1)